Patients achieved normal platelet count significantly faster with CABLIVI, in conjunction with PEX and immunosuppression2,4
%20(1)%20(2).2025-05-01-13-11-37.svg)
Treatment with CABLIVI, in conjunction with PEX and immunosuppression, resulted in a statistically significant reduction in time to platelet count response (P=0.01). Patients treated with CABLIVI were 55% more likely to achieve platelet count normalization at any given time point compared with patients treated with placebo2
*Platelet count normalization was defined as platelet count ≥150,000/μL with discontinuation of daily PEX 5 days thereafter.
†In conjunction with PEX and immunosuppression.
HR=hazard ratio.